ETF Holdings Breakdown of OLMA

OLMA institutional holdings

The adjusted close for OLMA on 2025-11-12 was 8.06

The following institutional investment holdings of OLMA have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-12	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	43,396	USD 349,772	8.06
2025-11-12	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	43,396 0.3%	USD 349,772 -1.3%	8.06
Total =		86,792	USD 699,544

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with OLMA

Analysts Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) PT at $24.00

Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six research firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating and five have assigned a buy rating to the company. The average 1-year target […] - 2025-08-18 02:09:40

Citigroup Forecasts Strong Price Appreciation for Olema Pharmaceuticals (NASDAQ:OLMA) Stock

Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report) had its target price boosted by equities researchers at Citigroup from $20.00 to $21.00 in a research note issued to investors on Tuesday, Marketbeat Ratings reports. The brokerage presently has a “buy” rating on the stock. Citigroup’s price target indicates a potential upside of 297.35% from the stock’s […] - 2025-08-14 03:07:13

Alps Advisors Inc. Has $190,000 Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)

Alps Advisors Inc. raised its holdings in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) by 9.0% in the first quarter, HoldingsChannel.com reports. The firm owned 50,484 shares of the company’s stock after buying an additional 4,149 shares during the period. Alps Advisors Inc.’s holdings in Olema Pharmaceuticals were worth $190,000 as of its […] - 2025-07-18 04:50:53

D. E. Shaw & Co. Inc. Decreases Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)

D. E. Shaw & Co. Inc. cut its holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) by 51.4% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 12,445 shares of the company’s stock after selling 13,148 shares during the quarter. D. E. Shaw & Co. Inc.’s holdings in Olema Pharmaceuticals were worth […] - 2025-05-29 04:58:52

Cubist Systematic Strategies LLC Purchases New Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)

Cubist Systematic Strategies LLC purchased a new stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 25,987 shares of the company’s stock, valued at approximately $152,000. A number of other hedge funds and other institutional investors have also recently bought and sold shares of […] - 2025-05-19 04:58:58

Hsbc Holdings PLC Buys New Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)

Hsbc Holdings PLC bought a new stake in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 10,005 shares of the company’s stock, valued at approximately $58,000. Several other hedge funds also recently added to […] - 2025-05-13 05:06:54

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Bought by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC grew its holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) by 1,436.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 22,714 shares of the company’s stock after acquiring an additional 21,236 shares during the quarter. […] - 2025-05-08 05:08:55

Olema Pharmaceuticals (NASDAQ:OLMA) Receives Buy Rating from HC Wainwright

Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They presently have a $30.00 target price on the stock. HC Wainwright’s price objective suggests a potential upside of 495.24% from the stock’s current price. OLMA has been […] - 2025-04-30 03:00:49

Franklin Resources Inc. Acquires 258,625 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)

Franklin Resources Inc. increased its holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) by 1,714.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 273,706 shares of the company’s stock after purchasing an additional 258,625 shares during the quarter. Franklin […] - 2025-04-15 05:06:53

Olema Pharmaceuticals (NASDAQ:OLMA) Earns “Buy” Rating from HC Wainwright

Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a note issued to investors on Wednesday,Benzinga reports. They presently have a $30.00 price objective on the stock. HC Wainwright also issued estimates for Olema Pharmaceuticals’ FY2029 earnings at ($2.41) EPS. Olema Pharmaceuticals Price Performance […] - 2025-03-21 04:56:48

AlphaQuest LLC Acquires 16,511 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)

AlphaQuest LLC raised its holdings in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) by 867.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,414 shares of the company’s stock after purchasing an additional 16,511 shares during the period. AlphaQuest LLC’s […] - 2025-03-19 06:10:45

Back to Listing

Disclaimer